Table of Content

1 Report Overview
1.1 Study Scope
1.2 Market Analysis by Type
1.2.1 Global RNAi Therapy Market Size Growth Rate by Type: 2018 VS 2022 VS 2033
1.2.2 Small Molecule Interfering Ribonucleic Acid (SiRNA)
1.2.3 Microrna (MiRNA)
1.3 Market by Application
1.3.1 Global RNAi Therapy Market Growth by Application: 2018 VS 2022 VS 2033
1.3.2 Oncology
1.3.3 Cardiology
1.3.4 Others
1.4 Study Objectives
1.5 Years Considered
1.6 Years Considered
2 Global Growth Trends
2.1 Global RNAi Therapy Market Perspective (2018-2033)
2.2 RNAi Therapy Growth Trends by Region
2.2.1 Global RNAi Therapy Market Size by Region: 2018 VS 2022 VS 2033
2.2.2 RNAi Therapy Historic Market Size by Region (2018-2023)
2.2.3 RNAi Therapy Forecasted Market Size by Region (2024-2033)
2.3 RNAi Therapy Market Dynamics
2.3.1 RNAi Therapy Industry Trends
2.3.2 RNAi Therapy Market Drivers
2.3.3 RNAi Therapy Market Challenges
2.3.4 RNAi Therapy Market Restraints
3 Competition Landscape by Key Players
3.1 Global Top RNAi Therapy Players by Revenue
3.1.1 Global Top RNAi Therapy Players by Revenue (2018-2023)
3.1.2 Global RNAi Therapy Revenue Market Share by Players (2018-2023)
3.2 Global RNAi Therapy Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
3.3 Players Covered: Ranking by RNAi Therapy Revenue
3.4 Global RNAi Therapy Market Concentration Ratio
3.4.1 Global RNAi Therapy Market Concentration Ratio (CR5 and HHI)
3.4.2 Global Top 10 and Top 5 Companies by RNAi Therapy Revenue in 2022
3.5 RNAi Therapy Key Players Head office and Area Served
3.6 Key Players RNAi Therapy Product Solution and Service
3.7 Date of Enter into RNAi Therapy Market
3.8 Mergers & Acquisitions, Expansion Plans
4 RNAi Therapy Breakdown Data by Type
4.1 Global RNAi Therapy Historic Market Size by Type (2018-2023)
4.2 Global RNAi Therapy Forecasted Market Size by Type (2024-2033)
5 RNAi Therapy Breakdown Data by Application
5.1 Global RNAi Therapy Historic Market Size by Application (2018-2023)
5.2 Global RNAi Therapy Forecasted Market Size by Application (2024-2033)
6 North America
6.1 North America RNAi Therapy Market Size (2018-2033)
6.2 North America RNAi Therapy Market Growth Rate by Country: 2018 VS 2022 VS 2033
6.3 North America RNAi Therapy Market Size by Country (2018-2023)
6.4 North America RNAi Therapy Market Size by Country (2024-2033)
6.5 United States
6.6 Canada
7 Europe
7.1 Europe RNAi Therapy Market Size (2018-2033)
7.2 Europe RNAi Therapy Market Growth Rate by Country: 2018 VS 2022 VS 2033
7.3 Europe RNAi Therapy Market Size by Country (2018-2023)
7.4 Europe RNAi Therapy Market Size by Country (2024-2033)
7.5 Germany
7.6 France
7.7 U.K.
7.8 Italy
7.9 Russia
7.10 Nordic Countries
8 Asia-Pacific
8.1 Asia-Pacific RNAi Therapy Market Size (2018-2033)
8.2 Asia-Pacific RNAi Therapy Market Growth Rate by Region: 2018 VS 2022 VS 2033
8.3 Asia-Pacific RNAi Therapy Market Size by Region (2018-2023)
8.4 Asia-Pacific RNAi Therapy Market Size by Region (2024-2033)
8.5 China
8.6 Japan
8.7 South Korea
8.8 Southeast Asia
8.9 India
8.10 Australia
9 Latin America
9.1 Latin America RNAi Therapy Market Size (2018-2033)
9.2 Latin America RNAi Therapy Market Growth Rate by Country: 2018 VS 2022 VS 2033
9.3 Latin America RNAi Therapy Market Size by Country (2018-2023)
9.4 Latin America RNAi Therapy Market Size by Country (2024-2033)
9.5 Mexico
9.6 Brazil
10 Middle East & Africa
10.1 Middle East & Africa RNAi Therapy Market Size (2018-2033)
10.2 Middle East & Africa RNAi Therapy Market Growth Rate by Country: 2018 VS 2022 VS 2033
10.3 Middle East & Africa RNAi Therapy Market Size by Country (2018-2023)
10.4 Middle East & Africa RNAi Therapy Market Size by Country (2024-2033)
10.5 Turkey
10.6 Saudi Arabia
10.7 UAE
11 Key Players Profiles
11.1 Alnylam
11.1.1 Alnylam Company Detail
11.1.2 Alnylam Business Overview
11.1.3 Alnylam RNAi Therapy Introduction
11.1.4 Alnylam Revenue in RNAi Therapy Business (2018-2023)
11.1.5 Alnylam Recent Development
11.2 Sarepta Therapeutics
11.2.1 Sarepta Therapeutics Company Detail
11.2.2 Sarepta Therapeutics Business Overview
11.2.3 Sarepta Therapeutics RNAi Therapy Introduction
11.2.4 Sarepta Therapeutics Revenue in RNAi Therapy Business (2018-2023)
11.2.5 Sarepta Therapeutics Recent Development
11.3 Alnylam Pharmaceuticals
11.3.1 Alnylam Pharmaceuticals Company Detail
11.3.2 Alnylam Pharmaceuticals Business Overview
11.3.3 Alnylam Pharmaceuticals RNAi Therapy Introduction
11.3.4 Alnylam Pharmaceuticals Revenue in RNAi Therapy Business (2018-2023)
11.3.5 Alnylam Pharmaceuticals Recent Development
11.4 Moderna
11.4.1 Moderna Company Detail
11.4.2 Moderna Business Overview
11.4.3 Moderna RNAi Therapy Introduction
11.4.4 Moderna Revenue in RNAi Therapy Business (2018-2023)
11.4.5 Moderna Recent Development
11.5 Sanofi
11.5.1 Sanofi Company Detail
11.5.2 Sanofi Business Overview
11.5.3 Sanofi RNAi Therapy Introduction
11.5.4 Sanofi Revenue in RNAi Therapy Business (2018-2023)
11.5.5 Sanofi Recent Development
11.6 Arcturus Therapeutics
11.6.1 Arcturus Therapeutics Company Detail
11.6.2 Arcturus Therapeutics Business Overview
11.6.3 Arcturus Therapeutics RNAi Therapy Introduction
11.6.4 Arcturus Therapeutics Revenue in RNAi Therapy Business (2018-2023)
11.6.5 Arcturus Therapeutics Recent Development
11.7 Silence
11.7.1 Silence Company Detail
11.7.2 Silence Business Overview
11.7.3 Silence RNAi Therapy Introduction
11.7.4 Silence Revenue in RNAi Therapy Business (2018-2023)
11.7.5 Silence Recent Development
11.8 Sirnaomics
11.8.1 Sirnaomics Company Detail
11.8.2 Sirnaomics Business Overview
11.8.3 Sirnaomics RNAi Therapy Introduction
11.8.4 Sirnaomics Revenue in RNAi Therapy Business (2018-2023)
11.8.5 Sirnaomics Recent Development
12 Analyst's Viewpoints/Conclusions
13 Appendix
13.1 Research Methodology
13.1.1 Methodology/Research Approach
13.1.2 Data Source
13.2 Disclaimer
13.3 Author Details

List of Figure

List of Tables
Table 1. Global RNAi Therapy Market Size Growth Rate by Type (US$ Million): 2018 VS 2022 VS 2033
Table 2. Key Players of Small Molecule Interfering Ribonucleic Acid (SiRNA)
Table 3. Key Players of Microrna (MiRNA)
Table 4. Global RNAi Therapy Market Size Growth by Application (US$ Million): 2018 VS 2022 VS 2033
Table 5. Global RNAi Therapy Market Size by Region (US$ Million): 2018 VS 2022 VS 2033
Table 6. Global RNAi Therapy Market Size by Region (2018-2023) & (US$ Million)
Table 7. Global RNAi Therapy Market Share by Region (2018-2023)
Table 8. Global RNAi Therapy Forecasted Market Size by Region (2024-2033) & (US$ Million)
Table 9. Global RNAi Therapy Market Share by Region (2024-2033)
Table 10. RNAi Therapy Market Trends
Table 11. RNAi Therapy Market Drivers
Table 12. RNAi Therapy Market Challenges
Table 13. RNAi Therapy Market Restraints
Table 14. Global RNAi Therapy Revenue by Players (2018-2023) & (US$ Million)
Table 15. Global RNAi Therapy Market Share by Players (2018-2023)
Table 16. Global Top RNAi Therapy Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in RNAi Therapy as of 2022)
Table 17. Ranking of Global Top RNAi Therapy Companies by Revenue (US$ Million) in 2022
Table 18. Global 5 Largest Players Market Share by RNAi Therapy Revenue (CR5 and HHI) & (2018-2023)
Table 19. Key Players Headquarters and Area Served
Table 20. Key Players RNAi Therapy Product Solution and Service
Table 21. Date of Enter into RNAi Therapy Market
Table 22. Mergers & Acquisitions, Expansion Plans
Table 23. Global RNAi Therapy Market Size by Type (2018-2023) & (US$ Million)
Table 24. Global RNAi Therapy Revenue Market Share by Type (2018-2023)
Table 25. Global RNAi Therapy Forecasted Market Size by Type (2024-2033) & (US$ Million)
Table 26. Global RNAi Therapy Revenue Market Share by Type (2024-2033)
Table 27. Global RNAi Therapy Market Size by Application (2018-2023) & (US$ Million)
Table 28. Global RNAi Therapy Revenue Market Share by Application (2018-2023)
Table 29. Global RNAi Therapy Forecasted Market Size by Application (2024-2033) & (US$ Million)
Table 30. Global RNAi Therapy Revenue Market Share by Application (2024-2033)
Table 31. North America RNAi Therapy Market Size Growth Rate by Country (US$ Million): 2018 VS 2022 VS 2033
Table 32. North America RNAi Therapy Market Size by Country (2018-2023) & (US$ Million)
Table 33. North America RNAi Therapy Market Size by Country (2024-2033) & (US$ Million)
Table 34. Europe RNAi Therapy Market Size Growth Rate by Country (US$ Million): 2018 VS 2022 VS 2033
Table 35. Europe RNAi Therapy Market Size by Country (2018-2023) & (US$ Million)
Table 36. Europe RNAi Therapy Market Size by Country (2024-2033) & (US$ Million)
Table 37. Asia-Pacific RNAi Therapy Market Size Growth Rate by Region (US$ Million): 2018 VS 2022 VS 2033
Table 38. Asia-Pacific RNAi Therapy Market Size by Region (2018-2023) & (US$ Million)
Table 39. Asia-Pacific RNAi Therapy Market Size by Region (2024-2033) & (US$ Million)
Table 40. Latin America RNAi Therapy Market Size Growth Rate by Country (US$ Million): 2018 VS 2022 VS 2033
Table 41. Latin America RNAi Therapy Market Size by Country (2018-2023) & (US$ Million)
Table 42. Latin America RNAi Therapy Market Size by Country (2024-2033) & (US$ Million)
Table 43. Middle East & Africa RNAi Therapy Market Size Growth Rate by Country (US$ Million): 2018 VS 2022 VS 2033
Table 44. Middle East & Africa RNAi Therapy Market Size by Country (2018-2023) & (US$ Million)
Table 45. Middle East & Africa RNAi Therapy Market Size by Country (2024-2033) & (US$ Million)
Table 46. Alnylam Company Detail
Table 47. Alnylam Business Overview
Table 48. Alnylam RNAi Therapy Product
Table 49. Alnylam Revenue in RNAi Therapy Business (2018-2023) & (US$ Million)
Table 50. Alnylam Recent Development
Table 51. Sarepta Therapeutics Company Detail
Table 52. Sarepta Therapeutics Business Overview
Table 53. Sarepta Therapeutics RNAi Therapy Product
Table 54. Sarepta Therapeutics Revenue in RNAi Therapy Business (2018-2023) & (US$ Million)
Table 55. Sarepta Therapeutics Recent Development
Table 56. Alnylam Pharmaceuticals Company Detail
Table 57. Alnylam Pharmaceuticals Business Overview
Table 58. Alnylam Pharmaceuticals RNAi Therapy Product
Table 59. Alnylam Pharmaceuticals Revenue in RNAi Therapy Business (2018-2023) & (US$ Million)
Table 60. Alnylam Pharmaceuticals Recent Development
Table 61. Moderna Company Detail
Table 62. Moderna Business Overview
Table 63. Moderna RNAi Therapy Product
Table 64. Moderna Revenue in RNAi Therapy Business (2018-2023) & (US$ Million)
Table 65. Moderna Recent Development
Table 66. Sanofi Company Detail
Table 67. Sanofi Business Overview
Table 68. Sanofi RNAi Therapy Product
Table 69. Sanofi Revenue in RNAi Therapy Business (2018-2023) & (US$ Million)
Table 70. Sanofi Recent Development
Table 71. Arcturus Therapeutics Company Detail
Table 72. Arcturus Therapeutics Business Overview
Table 73. Arcturus Therapeutics RNAi Therapy Product
Table 74. Arcturus Therapeutics Revenue in RNAi Therapy Business (2018-2023) & (US$ Million)
Table 75. Arcturus Therapeutics Recent Development
Table 76. Silence Company Detail
Table 77. Silence Business Overview
Table 78. Silence RNAi Therapy Product
Table 79. Silence Revenue in RNAi Therapy Business (2018-2023) & (US$ Million)
Table 80. Silence Recent Development
Table 81. Sirnaomics Company Detail
Table 82. Sirnaomics Business Overview
Table 83. Sirnaomics RNAi Therapy Product
Table 84. Sirnaomics Revenue in RNAi Therapy Business (2018-2023) & (US$ Million)
Table 85. Sirnaomics Recent Development
Table 86. Research Programs/Design for This Report
Table 87. Key Data Information from Secondary Sources
Table 88. Key Data Information from Primary Sources
List of Figures
Figure 1. Global RNAi Therapy Market Size Comparison by Type (2023-2033) & (US$ Million)
Figure 2. Global RNAi Therapy Market Share by Type: 2022 VS 2033
Figure 3. Small Molecule Interfering Ribonucleic Acid (SiRNA) Features
Figure 4. Microrna (MiRNA) Features
Figure 5. Global RNAi Therapy Market Size Comparison by Application (2023-2033) & (US$ Million)
Figure 6. Global RNAi Therapy Market Share by Application: 2022 VS 2033
Figure 7. Oncology Case Studies
Figure 8. Cardiology Case Studies
Figure 9. Others Case Studies
Figure 10. RNAi Therapy Report Years Considered
Figure 11. Global RNAi Therapy Market Size (US$ Million), Year-over-Year: 2018-2033
Figure 12. Global RNAi Therapy Market Size, (US$ Million), 2018 VS 2022 VS 2033
Figure 13. Global RNAi Therapy Market Share by Region: 2022 VS 2033
Figure 14. Global RNAi Therapy Market Share by Players in 2022
Figure 15. Global Top RNAi Therapy Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in RNAi Therapy as of 2022)
Figure 16. The Top 10 and 5 Players Market Share by RNAi Therapy Revenue in 2022
Figure 17. North America RNAi Therapy Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 18. North America RNAi Therapy Market Share by Country (2018-2033)
Figure 19. United States RNAi Therapy Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 20. Canada RNAi Therapy Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 21. Europe RNAi Therapy Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 22. Europe RNAi Therapy Market Share by Country (2018-2033)
Figure 23. Germany RNAi Therapy Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 24. France RNAi Therapy Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 25. U.K. RNAi Therapy Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 26. Italy RNAi Therapy Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 27. Russia RNAi Therapy Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 28. Nordic Countries RNAi Therapy Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 29. Asia-Pacific RNAi Therapy Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 30. Asia-Pacific RNAi Therapy Market Share by Region (2018-2033)
Figure 31. China RNAi Therapy Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 32. Japan RNAi Therapy Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 33. South Korea RNAi Therapy Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 34. Southeast Asia RNAi Therapy Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 35. India RNAi Therapy Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 36. Australia RNAi Therapy Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 37. Latin America RNAi Therapy Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 38. Latin America RNAi Therapy Market Share by Country (2018-2033)
Figure 39. Mexico RNAi Therapy Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 40. Brazil RNAi Therapy Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 41. Middle East & Africa RNAi Therapy Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 42. Middle East & Africa RNAi Therapy Market Share by Country (2018-2033)
Figure 43. Turkey RNAi Therapy Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 44. Saudi Arabia RNAi Therapy Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 45. Alnylam Revenue Growth Rate in RNAi Therapy Business (2018-2023)
Figure 46. Sarepta Therapeutics Revenue Growth Rate in RNAi Therapy Business (2018-2023)
Figure 47. Alnylam Pharmaceuticals Revenue Growth Rate in RNAi Therapy Business (2018-2023)
Figure 48. Moderna Revenue Growth Rate in RNAi Therapy Business (2018-2023)
Figure 49. Sanofi Revenue Growth Rate in RNAi Therapy Business (2018-2023)
Figure 50. Arcturus Therapeutics Revenue Growth Rate in RNAi Therapy Business (2018-2023)
Figure 51. Silence Revenue Growth Rate in RNAi Therapy Business (2018-2023)
Figure 52. Sirnaomics Revenue Growth Rate in RNAi Therapy Business (2018-2023)
Figure 53. Bottom-up and Top-down Approaches for This Report
Figure 54. Data Triangulation
Figure 55. Key Executives Interviewed